Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study.

Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study.

OBJECTIVE: To assess the efficacy and safety of intravenous administration of golimumab in patients with rheumatoid arthritis (RA). METHODS: Adult patients with RA in whom disease activity was persistent despite treatment with methotrexate (MTX) at a dosage of 15-25 mg/week for > or = 4 week...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Kremer, J, Ritchlin, C, Mendelsohn, A, Baker, D, Kim, L, Xu, Z, Han, J, Taylor, P
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2010

समान संसाधन

Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab.
द्वारा: Taylor, P, और अन्य
प्रकाशित: (2011)

The tumor necrosis factor-α inhibitor golimumab in the treatment of rheumatoid arthritis
द्वारा: Natalia Vladimirovna Chichasova
प्रकाशित: (2014-12-01)

Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study
द्वारा: Aaron Broadwell, और अन्य
प्रकाशित: (2023-03-01)

THE EFFECT OF GOLIMUMAB ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
द्वारा: L. A. Knyazeva, और अन्य
प्रकाशित: (2018-03-01)

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
द्वारा: Maini, R, और अन्य
प्रकाशित: (1998)

Celestina's Age: Is She Forty-Eight?
द्वारा: Anne Eesley
प्रकाशित: (2021-01-01)

Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age
द्वारा: John Tesser, और अन्य
प्रकाशित: (2019-08-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
द्वारा: M. Elaine Husni, और अन्य
प्रकाशित: (2022-03-01)

Edible art : forty-eight garnishes for the professional/
द्वारा: 230204 Larousse, David Paul
प्रकाशित: (1987)

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
द्वारा: Proton Rahman, और अन्य
प्रकाशित: (2020-09-01)

GOLIMUMAB SIGNIFICANTLY IMPROVES SELF-REPORTED PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
द्वारा: Wordsworth, P, और अन्य
प्रकाशित: (2009)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
द्वारा: M. Rossini, और अन्य
प्रकाशित: (2015-03-01)

Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis
द्वारा: Melissa A Michelon, और अन्य
प्रकाशित: (2010-05-01)

Paradoxical Reaction to Golimumab: Tumor Necrosis Factor α Inhibitor Inducing Psoriasis Pustulosa
द्वारा: Marien Siqueira Soto Lopes, और अन्य
प्रकाशित: (2013-11-01)

Effects of Eight Weeks of Core Stability Training on Serum level of Progranulin and Tumor Necrosis Factor Alpha in Women with Multiple Sclerosis
द्वारा: Maryam Karimi, और अन्य
प्रकाशित: (2021-01-01)

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
द्वारा: Elliott, M, और अन्य
प्रकाशित: (1994)

GOLIMUMAB, A HUMAN TNF-ALPHA mu ONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF-ALPHA AGENTS (GO-AFTER STUDY)
द्वारा: Wordsworth, P, और अन्य
प्रकाशित: (2009)

Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
द्वारा: Clifton O. Bingham, और अन्य
प्रकाशित: (2023-02-01)

Long-term results of golimumab therapy for rheumatoid arthritis. Therapy compliance issues
द्वारा: N. V. Chichasova
प्रकाशित: (2016-06-01)

Reagan at Reykjavik : forty-eight hours that ended the Cold War /
द्वारा: 238191 Adelman, Kenneth L.
प्रकाशित: (2014)

EFFECT OF GOLIMUMAB ON IMMUNOLOGICAL MARKERS FOR BONE METABOLISM AND ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
द्वारा: L. A. Knyazeva, और अन्य
प्रकाशित: (2018-07-01)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
द्वारा: Feldmann, M, और अन्य
प्रकाशित: (1997)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
द्वारा: Brennan, F, और अन्य
प्रकाशित: (1995)

Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial
द्वारा: Thomas Daix, और अन्य
प्रकाशित: (2023-03-01)

Golimumab for the treatment of psoriatic arthritis
द्वारा: H Yang, और अन्य
प्रकाशित: (2011-05-01)

Golimumab Therapy in Ulcerative Colitis
द्वारा: Won Moon
प्रकाशित: (2016-02-01)

Golimumab in the treatment of ulcerative colitis
द्वारा: Georgina Cunningham, और अन्य
प्रकाशित: (2019-01-01)

Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases
द्वारा: Manuel Pombo-Suárez, और अन्य
प्रकाशित: (2023-06-01)

Orlistat for the treatment of antipsychotic-induced weight gain: an eight-week multicenter, randomized, placebo-controlled, double-blind trial
द्वारा: Peng Xie, और अन्य
प्रकाशित: (2024-07-01)

The effect of eight-week yoga training on serum levels of interleukin 6, interleukin 10, tumor necrosis factor alpha and body composition in women with multiple sclerosis
द्वारा: Elham Maddah, और अन्य
प्रकाशित: (2024-08-01)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
द्वारा: Maini, R, और अन्य
प्रकाशित: (1995)

Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial
द्वारा: Philip Mease, और अन्य
प्रकाशित: (2020-03-01)

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
द्वारा: Ulfgren, A, और अन्य
प्रकाशित: (2000)

Persistence and Safety of Golimumab in Elderly Patients with Rheumatoid Arthritis and Renal Dysfunction in a Real-World Setting
द्वारा: Seiji Yokoyama, और अन्य
प्रकाशित: (2022-11-01)

Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritis
द्वारा: Federica Rivolta, और अन्य
प्रकाशित: (2023-03-01)

GOLIMUMAB SAFETY ACCORDING TO CLINICAL FINDINGS
द्वारा: G. V. Lukina, और अन्य
प्रकाशित: (2015-04-01)

The abilities of golimumab in the therapy of ankylosing spondylitis
द्वारा: Sh. F. Erdes
प्रकाशित: (2014-09-01)

Effectiveness and Safety of Golimumab in the Treatment of Ulcerative Colitis: 52-week Results from Post-marketing Surveillance in Japan
द्वारा: Shiro Nakamura, और अन्य
प्रकाशित: (2022-11-01)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
द्वारा: Elliot, M, और अन्य
प्रकाशित: (2008)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
द्वारा: Elliott, M, और अन्य
प्रकाशित: (1993)